Clinical trial

Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer

NCT03949270

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-07-22

PhaseNA

Study timeline

Study start (actual)2019-07-22Date precision: day

Registry last updated2023-11-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Adherence, Medicationunresolved

Side Effectunresolved

Interventions

BETA-Text text messaging interventionBEHAVIORAL

Sponsors & collaborators

Yale Universitylead sponsor

Mapped research locations

New HavenConnecticut, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03949270 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.